SLAIN2 activators encompass a diverse set of chemical compounds that indirectly influence the activity of the SLAIN2 protein, which plays a role in the regulation of microtubule dynamics within the cell. These activators do not interact with the SLAIN2 protein directly; instead, they affect various cellular pathways that can lead to alterations in SLAIN2 function. For instance, compounds that stabilize microtubules could enhance the microtubule-associated functions of SLAIN2, while those that disrupt microtubules might increase SLAIN2 activity through compensatory cellular mechanisms.
Moreover, since SLAIN2 activity is connected to the regulation of the cell cycle, any compound that affects cell cycle progression or cell division could influence SLAIN2 activity. Compounds such as forskolin and epidermal growth factor can elevate levels of secondary messengers or growth factors that indirectly modulate the protein's activity. Inhibition of enzymes like GSK-3 through lithium chloride, or the activation of kinase pathways by agents such as PMA, illustrates the broad spectrum of indirect activators that can, through various means, impact the function of SLAIN2 in the context of cellular signaling and structural maintenance.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules and could indirectly enhance SLAIN2 activity by stabilizing the structures it associates with. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, leading to increased cAMP and potentially enhancing SLAIN2 activity via PKA signaling. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Can influence cell cycle progression and might affect SLAIN2 function indirectly. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3, which could affect SLAIN2 activity through Wnt signaling pathway modulation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Influences cell differentiation and proliferation, potentially affecting SLAIN2 activity. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Causes DNA damage, possibly triggering a cellular response that enhances SLAIN2 activity. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Inhibits cyclin-dependent kinases, which could lead to adjustments in SLAIN2 activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Increases intracellular calcium, which can modulate various cell signaling pathways including those involving SLAIN2. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, possibly influencing SLAIN2 activity as part of signal transduction processes. | ||||||